Sunshine Lake Pharma Company Description

Sunshine Lake Pharma Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products for the treatment of infectious diseases, chronic diseases, and oncology.

It offers Kewei for the treatment of influenza; Dongweien for the treatment of hepatitis C; and generic drugs for the treatment of infections caused by sensitive bacteria, namely Clarithromycin, Levofloxacin, and Moxifloxacin Hydrochlorid, as well as active pharmaceutical ingredients.

The company also engages in the wholesale, retail, import, and export of drugs. The company was formerly known as Sunshine Lake Pharma Ltd. The company was incorporated in 2001 and is based in Dongguan, China.

Sunshine Lake Pharma Co., Ltd.

Country	China
Founded	2001
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	4,861
CEO	Wenjia Li

Contact Details

Address: HEC Scientific Park Dongguan China
Website	hecpharm.com

Stock Details

Ticker Symbol	6887
Exchange	Hong Kong Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
SIC Code	2834

Key Executives

Name	Position
Qiang Zhang CPA	Chief Financial Officer and Head of Finance Department
Qiyun Peng	Joint Company Secretary
Danjin Wang	Deputy General Manager
Shuang Li	Deputy General Manager
Dr. Yingjun Zhang	Executive Chairman
Dr. Wenjia Li	GM and Executive Director
Yangui Chen	Head of the Sales Department
Shengchao Wang	Chief of Quality Division and Employee Representative Supervisor
Wai Chiu Wong C.P.A., CTP, FCS	Joint Company Secretary